| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2574763 | Vascular Pharmacology | 2009 | 6 Pages |
Abstract
We show that the immunosuppressive agent FK778 can prevent neointima formation in experimental venous bypass grafts by inhibiting venous SMC proliferation. FK778 might provide a new pharmacological therapy to limit vein graft stenosis and bypass graft failure.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Rick de Graaf, Geoffrey Kloppenburg, Andrei Tintu, Ellen Rouwet, Peter Kitslaar, Johannes van Hooff, Cathrien Bruggeman, Frank Stassen,